BIOL
$0.80
Biolase
($.20)
(20.00%)
BIOL
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.17)
Revenue:  $11.48 Mil
Wednesday
Nov 6
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Guidance announcement made Thursday, August 08, 2019
Latest EPS
Thursday, August 08, 2019

What do you expect when BIOL reports earnings?
Beat
Meet
Miss

Where is BIOL's stock price going from here?
Up
Flat
Down
Stock chart of BIOL
Analysts
Summary of analysts' recommendations for BIOL
Score
Grade
Pivots
Resistance
$1.22
$1.13
$0.97

$0.87

Support
$0.71
$0.62
$0.45
Tweet
Growth
Description
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.